Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations (2012 - 2013)
Ani Pharmaceuticals' (ANIP) quarterly Liabilities from Discontinued Operations came in at 131613.0 in Q3 2013, down 64.08% quarter-over-quarter from 366390.0 in Q2 2013.
Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations (2012 - 2013) Analysis & Trends
Ani Pharmaceuticals has disclosed Liabilities from Discontinued Operations across 2 years of filings, most recently posting 131613.0 for Q3 2013.
- Liabilities from Discontinued Operations for Q3 2013 came in at 131613.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2013 was 131613.0 (changed N/A YoY), and the FY2012 annual result was 370766.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at 131613.0 for Q3 2013 at Ani Pharmaceuticals, down from 366390.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 370766.0 in Q4 2012 to a low of 131613.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Ani Pharmaceuticals | 1.71 Bn | 1.40 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 131,613.00 |
| Sep 30, 2013 | 131,613.00 |
| Jun 30, 2013 | 366,390.00 |
| Jun 30, 2013 | 366,390.00 |
| Dec 31, 2012 | 370,766.00 |
| Dec 31, 2012 | 370,766.00 |